Status:
NOT_YET_RECRUITING
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Lead Sponsor:
AstraZeneca
Conditions:
Lung Neoplasms
Eligibility:
All Genders
18-130 years
Brief Summary
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and hea...
Eligibility Criteria
Inclusion
- Patients with lung cancer between January 1, 2018 and end of the Selection Period.
- Patient is 18 years of age or older on diagnosis date.
- Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
Exclusion
- Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
- Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
- Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
- Non-Ontario or non-Alberta resident on diagnosis date.
Key Trial Info
Start Date :
August 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
60000 Patients enrolled
Trial Details
Trial ID
NCT07143110
Start Date
August 20 2025
End Date
September 30 2027
Last Update
August 27 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.